Loading…
Tuesday, June 26 • 10:30am - 12:00pm
#243: Global Perspectives on Patient Engagement

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-18-586-L04-P; CME 1.50; IACET 1.50; RN 1.50

In Europe and North America, patient engagement in drug development is now expected, though not perfect. In this session, a panel of patient, industry, and regulator stakeholders will discuss the thinking and initiatives in other global regions to give patients a voice. We will look beyond Europe and North America to explore the thinking and efforts in other regions to engage patients in the medical product lifecycle. What efforts are underway or emerging to give patients a voice? What cultural, societal, and economic factors drive current thoughts and practices? Who are the influencers who are encouraging change? A diverse panel representing patient groups, regulators and industry from regions such as Asia and Latin America will talk about current experience, hopes, and aspirations for patient engagement worldwide.

Learning Objectives

Describe current practices for patient engagement in drug development and regulation in regions such as Asia and Latin America; Compare and contrast perspectives of patient, industry, and regulator stakeholders within these regions; Discuss cultural, societal, and other factors playing a role in views, practices, and emerging trends on patient engagement in these regions.

Chair

Mathieu Boudes, PhD

Speaker

Panelist
Junko Sato, PhD

Panelist
Jan Nissen, BSN, MBA

Panelist
Durhane Wong-Rieger

Panelist
Young Jack Lee, PhD

Panelist
Jieun Lee, RPh



Speakers
avatar for Mathieu Boudes

Mathieu Boudes

PARADIGM Coordinator, European Patients' Forum
Mathieu Boudes, PhD, joined the European Patients’ Forum (EPF) in 2018 as coordinator of the PARADIGM project, a public-private partnership financed by the Innovative Medicines Initiative and co-led by EPF and EFPIA (European Federation of Pharmaceutical Industries and Associations... Read More →
avatar for Young Jack Lee

Young Jack Lee

Chief Executive Officer, LSK Global PS
Dr. Young Jack Lee is a experienced biostastician. He started the biostatistics career at the US NIH, his last position being an NIH Biometry Branch Chief. He returned to Korea in 1999 to teach and started LSK Global PS, a full service Korean CRO in 2000. His company with 320 employees... Read More →
JL

Jieun Lee

Assistant Director, Ministry of Food and Drugs Safety
Joined MFDS in 2012 and she is an Assistant Director of Clinical Trial Management Division since 2018.
avatar for Jan Nissen

Jan Nissen

Vice President, Patient Innovation & Engagement, Merck & Co., Inc.
Jan leads Merck’s Patient Innovation & Engagement organization comprised of Patient Insights, Patient & Consumer Experience, and Patient and Caregiver Alliances & Advocacy globally. She has been in the pharmaceutical industry over 30 years, serving in sales, training, marketing... Read More →
avatar for Junko Sato

Junko Sato

Office Director, Office of International Cooperation, Pharmaceuticals and Medical Devices Agency (PMDA)
She joined the agency in 1998. She has work experiences in new drug review for 11 yrs, risk management for 3 yrs and international area for 6yrs. She also worked in U.S.FDA as a guest reviewer 2002-2003, and in EMA as the Japan Liaison Officer, 2012-2014. She is actively involved... Read More →
avatar for Durhane Wong-Rieger

Durhane Wong-Rieger

President and Chief Executive Officer, Canadian Organization For Rare Disorders
Durhane Wong-Rieger, PhD, is President, Institute for Optimizing Health Outcomes; President; Canadian Organization for Rare Disorders; Chair, Consumer Advocare Network; Past-Chair, International Alliance of Patient Organizations; Co-Chair, HTAi Patient / Citizen Involvement IG; Board... Read More →


Tuesday June 26, 2018 10:30am - 12:00pm
Room 210AB Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA